| Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance JD Walter, M Scherer, CAJ Hutter, AA Garaeva, I Zimmermann, M Wyss, ... EMBO reports 23 (4), e54199, 2022 | 36 | 2022 |
| Highly potent bispecific sybodies neutralize SARS-CoV-2 JD Walter, CA Hutter, AA Garaeva, M Scherer, I Zimmermann, M Wyss, ... | 10 | 2020 |
| LRP6 Is a Functional Receptor for Attenuated Canine Distemper Virus V Gradauskaite, M Inglebert, J Doench, M Scherer, M Dettwiler, M Wyss, ... Mbio 14 (1), e03114-22, 2023 | 2 | 2023 |
| Novel nasal virosome spray vaccine to protect against COVID-19 TP Cremona, BV Ozan, M Scalise, M Scherer, S Mutlu, AB Tschirren, ... ERJ Open Research 8 (suppl 8), 2022 | 1 | 2022 |
| Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation NGF Leborgne, C Devisme, N Kozarac, IB Veiga, N Ebert, A Godel, ... JCI insight 9 (7), 2024 | | 2024 |
| Highly potent bispecific sybodies neutralize SARS-CoV-2 (preprint) JD Walter, CAJ Hutter, AA Garaeva, M Scherer, I Zimmermann, M Wyss, ... | | 2020 |
